Jennifer Venhorst

P07-001Development of an intelligence platform for efficient drug Target Safety Assessments

E. P. van Someren, Cyrille Krul, F. J. van de Brug, 2016 .

Design of a high fragment efficiency library by molecular graph theory.

Jennifer Venhorst, Sara Núñez, Chris G. Kruse, 2010, ACS medicinal chemistry letters.

Assessment of a Novel Scoring Method Based on Solvent Accessible Surface Area Descriptors

Jennifer Venhorst, Sara Núñez, Chris G. Kruse, 2010, J. Chem. Inf. Model..

Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.

Chris Oostenbrink, Natalia Markova, Jennifer Venhorst, 2011, European journal of medicinal chemistry.

Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities.

Nico P E Vermeulen, Jennifer Venhorst, J. Venhorst, 2003, Journal of medicinal chemistry.

Target-drug interactions: first principles and their application to drug discovery.

Jennifer Venhorst, J. Venhorst, C. Kruse, 2012, Drug discovery today.

Assessment of scaffold hopping efficiency by use of molecular interaction fingerprints.

Chris G. Kruse, Jennifer Venhorst, J. Venhorst, 2008, Journal of medicinal chemistry.

N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.

Jennifer Venhorst, J. Venhorst, M. V. van Dongen, 2011, Journal of medicinal chemistry.